OLON

Olon USA

@olon_usa

Concord, OH
http://www.olon-usa.com
Pharmaceutical Manufacturing

Overview

About Olon USA

Who we are:

On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe.

Olon USA is a US-based CDMO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Olon USA’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon USA has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients.

Company Details

Website:
http://www.olon-usa.com

Location:
Concord, OH
Florham Park, NJ

Headquarters

Concord, OH

Website

http://www.olon-usa.com

Company Size

51-200 employees

Industry

Pharmaceutical Manufacturing

Company Type

Privately Held

Founded

2026

Specialties

Chemical Development, Synthetic Chemistry, Analytical Services, CRO, CDMO, API, GMP, GLP, Drug Substance, and generic

Posts